Companies
Natera Builds Data Backing Serial ctDNA Changes to Aid CRC Patient Management, Treatment Decisions
Premium
The company believes its findings are the first to show that quantifying ctDNA changes can stratify high-risk colorectal cancer patients into better and worse prognostic groups.
In Brief This Week: Quanterix, Cue Health, Hologic, CareDx, and More
News items for the in vitro diagnostics industry for the week of Oct. 11, 2021.
Roche, PathAI Partner to Develop, Distribute AI-Based Digital Pathology Diagnostics
The companies will jointly develop an embedded image analysis workflow for pathologists that integrates PathAI algorithms into Roche's Navify software.
FDA Classifies Abbott SARS-CoV-2 Molecular Test Recall as Class I Due to False Positives
Last month, the agency alerted users to the potential of false positives due to overflow of the PCR reaction mixture into neighboring wells of the assay reagent tray.
Cepheid Obtains CE Mark for Expanded Combo COVID Test
The new test adds a third target for SARS-CoV-2 to enable better detection of the virus should it mutate further in the future.